References
- Ferlin A, Raicu F, Gatta V, et al. Male infertility: role of genetic background. Reprod Bio Med Online 2007;14:734–45
- Wang RX, Fu C, Yang YP, et al. Male infertility in China: laboratory finding for AZF microdeletions and chromosomal abnormalities in infertile men from Northeastern China. J Assist Reprod Genet 2010;27:391–6
- Seul KK, Jung RL, Byung CJ, et al. What number of oocytes is appropriate for defining poor ovarian response? Yonsei Med J 2015;56:482–9
- Min JK, Hye WC, So YP, et al. Molecular and cytogenetic studies of 101 infertile men with microdeletions of Y chromosome in 1,306 infertile Korean men. J Assist Reprod Genet 2012;29:539–46
- Vander Merwe FH, Kruger TF, Oehninger SC, Lombard CJ. The use of semen parameters to identify the subfertile male in the general population. Gynecol Obstet Invest 2005;59:86–91
- Kruger TF, Acosta AA, Simmons KF, et al. Predictive value of abnormal sperm morphology in in vitro fertilization. Fertil Steril 1988;49:112–17
- Oehninger S, Kruger TF, Simon T, et al. A comparative analysis of embryo implantation potential in patients with severe teratozoospermia undergoing in-vitro fertilization with a high insemination concentration or intracytoplasmic sperm injection. Hum Reprod 1996;11:1086–9
- Check JH, Bollendorf A, Wilson C, et al. A retrospective comparison of pregnancy outcome following conventional oocyte insemination vs intracytoplasmic sperm injection for isolated abnormalities in sperm morphology using strict criteria. Andrologia 2007;28:607–12
- Berger DS, Abdelhafez F, Russell H, et al. Severe teratozoospermia and its influence on pronuclear morphology, embryonic cleavage and compaction. Reprod Biol Endocrinol 2011;9:37
- Hotaling JM, Smith JF, Rosen M, et al. The relationship between isolated teratozoospermia and clinical pregnancy after in vitrofertilization with or without tintracytoplasmic sperm injection: a systematic review and meta-analysis. Fertil Steril 2011;95:1141–5
- Boulet SL, Mehta A, Kissin DM, et al. Trends in use of and reproductive outcomes associated with intracytoplasmic sperm injection. JAMA 2015;313:255–63
- Eftekhar M, Mohammadian F, Yousefnejad F, et al. Comparison of conventional IVF versus ICSI in non-male factor, normoresponder patients. Iran J Reprod Med 2012;10:131–6
- Li B, Ma YF, Huang JL, et al. Probing the effect of human normal sperm morphologyrate on cycle outcomes and assisted reproductive methods selection. Plos One 2014;9:e113392
- Shi WH, Zhang SL, Zhao WQ, et al. Factors related to clinical pregnancy after vitrified–warmed embryo transfer: a retrospective and multivariate logistic regression analysis of 2313 transfer cycles. Hum Reprod 2013;28:1768–75
- Keegan BR, Barton S, Sanchez X, et al. Isolated teratozoospermia does not affect in vitro fertilization outcome and is not an indication for intracytoplasmic sperm injection. Fertil Steril 2007;88:1583–8
- Sallam HN, Ezzeldin F, Agameya AF, et al. The definition of ‘poor response’: Bologna criteria. Hum Reprod 2012;27:626–7
- Gleicher N, Weghofer A, Barad DH. Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Fertil Steril 2010;94:2824–7